ENTA
Price
$5.63
Change
+$0.06 (+1.08%)
Updated
Apr 28, 04:59 PM (EDT)
Capitalization
119.04M
14 days until earnings call
LGVN
Price
$1.68
Change
-$0.07 (-4.00%)
Updated
Apr 28, 02:35 PM (EDT)
Capitalization
26.18M
Ad is loading...

ENTA vs LGVN

Header iconENTA vs LGVN Comparison
Open Charts ENTA vs LGVNBanner chart's image
Enanta Pharmaceuticals
Price$5.63
Change+$0.06 (+1.08%)
Volume$3.71K
Capitalization119.04M
Longeveron
Price$1.68
Change-$0.07 (-4.00%)
Volume$100
Capitalization26.18M
ENTA vs LGVN Comparison Chart
Loading...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTA vs. LGVN commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTA is a Hold and LGVN is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (ENTA: $5.58 vs. LGVN: $1.75)
Brand notoriety: ENTA and LGVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTA: 60% vs. LGVN: 57%
Market capitalization -- ENTA: $119.04M vs. LGVN: $26.18M
ENTA [@Biotechnology] is valued at $119.04M. LGVN’s [@Biotechnology] market capitalization is $26.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTA’s FA Score shows that 1 FA rating(s) are green whileLGVN’s FA Score has 0 green FA rating(s).

  • ENTA’s FA Score: 1 green, 4 red.
  • LGVN’s FA Score: 0 green, 5 red.
According to our system of comparison, ENTA is a better buy in the long-term than LGVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTA’s TA Score shows that 5 TA indicator(s) are bullish while LGVN’s TA Score has 6 bullish TA indicator(s).

  • ENTA’s TA Score: 5 bullish, 5 bearish.
  • LGVN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, LGVN is a better buy in the short-term than ENTA.

Price Growth

ENTA (@Biotechnology) experienced а +9.41% price change this week, while LGVN (@Biotechnology) price change was +19.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.19%. For the same industry, the average monthly price growth was +1.10%, and the average quarterly price growth was -9.09%.

Reported Earning Dates

ENTA is expected to report earnings on Aug 11, 2025.

LGVN is expected to report earnings on Feb 28, 2025.

Industries' Descriptions

@Biotechnology (+11.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENTA($119M) has a higher market cap than LGVN($26.2M). LGVN YTD gains are higher at: 1.156 vs. ENTA (-2.957). LGVN has higher annual earnings (EBITDA): -15.56M vs. ENTA (-94.42M). ENTA has more cash in the bank: 217M vs. LGVN (19.2M). LGVN has less debt than ENTA: LGVN (1.45M) vs ENTA (57.5M). ENTA has higher revenues than LGVN: ENTA (66.6M) vs LGVN (2.39M).
ENTALGVNENTA / LGVN
Capitalization119M26.2M454%
EBITDA-94.42M-15.56M607%
Gain YTD-2.9571.156-256%
P/E RatioN/AN/A-
Revenue66.6M2.39M2,784%
Total Cash217M19.2M1,130%
Total Debt57.5M1.45M3,974%
FUNDAMENTALS RATINGS
ENTA: Fundamental Ratings
ENTA
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTALGVN
RSI
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
89%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
69%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 21 days ago
83%
Bearish Trend 21 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
63%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
View a ticker or compare two or three
Ad is loading...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KRKNF1.780.04
+2.30%
Kraken Robotics Inc.
FRAAX51.480.59
+1.16%
Franklin Growth Opportunities Adv
EVSYX22.860.19
+0.84%
Allspring Disciplined US Core Admin
JTKWY4.320.02
+0.47%
Just Eat Takeaway.com N.V.
GELYY41.42-0.01
-0.02%
Geely Automobile Holdings Ltd.

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with RNA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
+7.36%
RNA - LGVN
37%
Loosely correlated
-0.29%
SRPT - LGVN
34%
Loosely correlated
-2.14%
ENTA - LGVN
34%
Loosely correlated
-1.59%
FATE - LGVN
33%
Loosely correlated
-5.19%
AXON - LGVN
30%
Poorly correlated
+2.22%
More